ALVO
AlvotechFNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-18
Current thesis
Composite grade F from latest DB weights. Momentum 3.7 / Value 52.0
Posture
Defensive
Lead driver
Value
What changed
Value remains the lead driver in the composite, 7D delta -0.2.
What can break
Mixed signals. Wait for cleaner trend confirmation.
Momentum
4
Value
52
Sentiment
N/A
Setup hits (3d)
0 · Net Neutral
AI TargetsBase - · Bull - · Bear -
Data freshness
Prices
As of 2026-07-18
Fundamentals
As of 2026-07-20 • Vendor: Data Vendor v1
Scores
As of 2026-07-18 • Model: HYBRID_IC_RP
AI Memo
Unavailable: No memo yet
Investment thesisAs of 2026-07-18
Investment thesis
As of 2026-07-18
Supporting evidence
What
Grade F · Defensive
Confidence Medium · Net Neutral
Target $6.20
Why
Momentum4 · Δ7d -4.2
Value52 · Δ7d -0.2
SentimentN/A · Δ7d -
So what
Weak posture (Net Neutral). Prioritize risk control and patience.
Lead driver: Value · See fundamentals
Momentum
4
40% active weight
Current posture
7d trendSoftening
Δ7d
-4.2
Δ21d
-48.4
Value
52
60% active weight
Current posture
7d trendFlat
Δ7d
-0.2
Δ21d
+0.1
Sentiment
N/A
Coverage pending
No current score
7d trendTrend unavailable
Trend unavailable
Δ7d
-
Δ21d
-
Why this grade
Composite grade F. Momentum 3.7 / Value 52.0
Fundamentals (TTM)As of 2026-07-20
Fundamentals (TTM)
As of 2026-07-20
Market Cap
$1.15B
Beta
0.12
Shares Out
390.43M
P/E (TTM)
23.4
P/S (TTM)
2.66
P/FCF (TTM) · Derived
-5.40
Rev YoY
-20.3%
EPS YoY
-99.1%
Gross Margin
+61.4%
Op Margin
+12.1%
Net Debt
$1.28B
Current Ratio
1.76
As of 2026-07-18 • Updated nightlySource: Internal modelMethodology